The primary care of Alzheimer disease

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Alzheimer disease is the most common cause of progressive irreversible intellectual loss in aging humans. The number of individuals and families affected by this disorder will continue to grow as society ages worldwide. Our understanding of the biology, underlying pathophysiology, and diagnosis of Alzheimer disease has greatly expanded over the past few years and much has been published in these areas. This review focuses on the primary care of this disorder and addresses the "now what" question. Topics examined include limiting excess disability, responding to commonly raised questions of family members, pharmacologic and nonpharmacologic therapeutic options, long-term planning, and caregiver issues.

Original languageEnglish (US)
Pages (from-to)314-333
Number of pages20
JournalAmerican Journal of the Medical Sciences
Volume332
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Primary Health Care
Alzheimer Disease
Caregivers
Therapeutics

Keywords

  • Alzheimer disease
  • Caregivers
  • Cholinesterase inhibitors
  • Dementia
  • Family risk

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The primary care of Alzheimer disease. / Rubin, Craig D.

In: American Journal of the Medical Sciences, Vol. 332, No. 6, 12.2006, p. 314-333.

Research output: Contribution to journalArticle

@article{e547283de8cf403b8e54c5e0c78c4d00,
title = "The primary care of Alzheimer disease",
abstract = "Alzheimer disease is the most common cause of progressive irreversible intellectual loss in aging humans. The number of individuals and families affected by this disorder will continue to grow as society ages worldwide. Our understanding of the biology, underlying pathophysiology, and diagnosis of Alzheimer disease has greatly expanded over the past few years and much has been published in these areas. This review focuses on the primary care of this disorder and addresses the {"}now what{"} question. Topics examined include limiting excess disability, responding to commonly raised questions of family members, pharmacologic and nonpharmacologic therapeutic options, long-term planning, and caregiver issues.",
keywords = "Alzheimer disease, Caregivers, Cholinesterase inhibitors, Dementia, Family risk",
author = "Rubin, {Craig D.}",
year = "2006",
month = "12",
doi = "10.1097/00000441-200612000-00004",
language = "English (US)",
volume = "332",
pages = "314--333",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The primary care of Alzheimer disease

AU - Rubin, Craig D.

PY - 2006/12

Y1 - 2006/12

N2 - Alzheimer disease is the most common cause of progressive irreversible intellectual loss in aging humans. The number of individuals and families affected by this disorder will continue to grow as society ages worldwide. Our understanding of the biology, underlying pathophysiology, and diagnosis of Alzheimer disease has greatly expanded over the past few years and much has been published in these areas. This review focuses on the primary care of this disorder and addresses the "now what" question. Topics examined include limiting excess disability, responding to commonly raised questions of family members, pharmacologic and nonpharmacologic therapeutic options, long-term planning, and caregiver issues.

AB - Alzheimer disease is the most common cause of progressive irreversible intellectual loss in aging humans. The number of individuals and families affected by this disorder will continue to grow as society ages worldwide. Our understanding of the biology, underlying pathophysiology, and diagnosis of Alzheimer disease has greatly expanded over the past few years and much has been published in these areas. This review focuses on the primary care of this disorder and addresses the "now what" question. Topics examined include limiting excess disability, responding to commonly raised questions of family members, pharmacologic and nonpharmacologic therapeutic options, long-term planning, and caregiver issues.

KW - Alzheimer disease

KW - Caregivers

KW - Cholinesterase inhibitors

KW - Dementia

KW - Family risk

UR - http://www.scopus.com/inward/record.url?scp=33845760457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845760457&partnerID=8YFLogxK

U2 - 10.1097/00000441-200612000-00004

DO - 10.1097/00000441-200612000-00004

M3 - Article

C2 - 17170622

AN - SCOPUS:33845760457

VL - 332

SP - 314

EP - 333

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 6

ER -